ÐÒÔË·Éͧ¼Æ»®

Home
Department of Clinical Medicine

News archive for Department of Clinical Medicine

Although CCBIO this summer completes its 10-year appointment as Center of Excellence by the Research Council of Norway, the center will continue its activities, and so do all the research groups and collaborations that have been established through these years. It has been a privilege for the CCBIO leadership to follow these groups from the very beginning and watch them grow and now continue to... Read more
The 12th CCBIO Annual Symposium took place May 14-15, 2024, at Solstrand outside of Bergen in excellent weather, facilitating a radiant frame for networking and meetings in the sunshine during the breaks. The program showcased current cancer biomarker research as well as taking a step back considering global perspectives on cancer.
Did you know that ÐÒÔË·Éͧ¼Æ»® coordinates a European initiative to target the cause of MS?
During 2017-2019, systematic differences in high efficacy MS-treatment strategies were preferred in Oslo (cladribine) and Bergen (rituximab). Comparisons of long-term (median 4.5 years) effects from these different treatments showed a 2.7 higher risk for new MRI disease activity after four years in the cladribine group (n=132) compared to rituximab group (n=168).
This years Annual Research Presentations by the Research School in Clinical Medicine.
CCBIO PhD candidate Marta Espevold Hjelmeland in the Krakstad group spends the second year of her PhD program in Boston.
The regional health authority Helse Vest’s Research Award 2023 goes to Professor Lars Andreas Akslen and CCBIO for ground-breaking research on cancer biomarkers. Akslen has also been subject to another prestigious recognition this fall, as he was recently elected as member of the Academia Europaea.
Mari Kyllesø Halle received a frame allocation of NOK 8 million in the Researcher Projects 2023 call from the Norwegian Cancer Association, for the project "Decoding the Landscape of Cancer Vulnerabilities in high-risk Cervical Carcinomas to detect new treatment strategies." CCBIO is proud to see this CCBIO Masterclass alumna as a project leader for the first time.
Emmet McCormack will be part of the new COST Action IMMUNO-model, where a network of scientists involved in the development and implementation of preclinical models evaluating the response and toxicity induced by immunotherapies, is challenged to expand our knowledge in their mechanisms of action and improve the survival and quality of life of cancer patients.
The very first Neuro-SysMed Annual Symposium took place at the historic Solstrand Hotel outside of Bergen, September 25-26, 2023. The dramatic western Norway weather did not entice to stepping out into the beautiful fjord surroundings, but all the 114 participants did nevertheless enjoy social and scientific radiance indoors.
Forsker Grand Prix took place in Bergen September 27, where nine young researchers were competing for Best Presenter, getting only four minutes to convey their research in front of an audience and three judges. Among the nine was CCBIO's and the Department of Clinical Science's PhD Candidate Christiane Helgestad Gjerde.
Research advisors at the Faculty of Medicine have recently launched a new portal for researchers applying for external funding.
Researchers launch pioneering EU funded research initiative to uncover role of Epstein-Barr virus in multiple sclerosis, building on recent research breakthrough.
Understanding the neural control of movement and how it evolved is critical to better address neurodegenerative diseases. In a recent study, researchers discovered that neuronal networks controlling movement in humans and tunicates have the same building blocks, structure, and function.
The 11th CCBIO Annual Symposium was this time enlarged with a generous time frame and two overnight stays, May 8-11, 2023. Although there was an option for online attendance, only 14 participants chose to attend online, and the rest of the total of 235 chose to enjoy the company of colleagues and the informal and mutually fertilizing scientific crosstalk in the breaks and the evenings.
This winter/spring, three of CCBIO's students got the opportunity to have research stays at different labs of the Vascular Biology Program in Boston, through CCBIO's INTPART collaboration with Harvard Medical School and Boston Children's Hospital. PhD Candidate Camilla Tvedt Ekanger, Medical Student Research Program student Amalie Bark Kvamme and PhD Candidate Ole Vidhammer Bjørnstad are now back... Read more

Pages